Lv1
86 积分 2024-11-25 加入
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection
5天前
已完结
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
5天前
已完结
Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication
5天前
已完结
Myricetin supresses HBV replication both in vitro and in vivo via inhibition of HBV promoter SP2
5天前
已完结
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
5天前
已完结
Therapeutic Gene Editing: DNA Repair Pathways, Emerging Editors, and Clinical Progress
1个月前
已完结
Discovery of hypercompact epigenetic modulators for persistent CRISPR-mediated gene activation
1个月前
已完结
P309 EPI-321: A promising gene therapy for facioscapulohumeral muscular dystrophy (FSHD) targeting D4Z4 epigenome
1个月前
已完结
A phase I, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ADCT-601 in patients with advanced solid tumours
1个月前
已完结
640P Efficacy and safety of EPI-321, an investigational single dose epigenome editing therapy targeting D4Z4 in facioscapulohumeral Muscular Dystrophy (FSHD)
1个月前
已完结
皖公网安备34019202002308
